CEA as a Marker for Medullary Thyroid Carcinoma in a Patient with Colorectal Cancer

Authors

  • Parul Goyal, MBBS University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Rami Mortada, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Rawaa Ebrahem, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS
  • Salam Kadhem, M.D. University of Kansas School of Medicine-Wichita Department of Internal Medicine, Wichita, KS

DOI:

https://doi.org/10.17161/kjm.v9i4.8630

Keywords:

carcinoembryonic antigen, medullary thyroid cancer, MEN 2A syndrome

Downloads

Published

2019-01-08

How to Cite

Goyal, P., Mortada, R., Ebrahem, R., & Kadhem, S. (2019). CEA as a Marker for Medullary Thyroid Carcinoma in a Patient with Colorectal Cancer. Kansas Journal of Medicine, 9(4), 109–110. https://doi.org/10.17161/kjm.v9i4.8630

Issue

Section

Case Reports